Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial. - Zeyen T; Potthoff AL; Nemeth R; Heiland DH; Burger MC; Steinbach JP; Hau P; Tabatabai G; Glas M; Schlegel U; Grauer O; Krex D; et al. (Trials, 2022)